AR009651A1 - Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas - Google Patents

Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas

Info

Publication number
AR009651A1
AR009651A1 ARP970105696A ARP970105696A AR009651A1 AR 009651 A1 AR009651 A1 AR 009651A1 AR P970105696 A ARP970105696 A AR P970105696A AR P970105696 A ARP970105696 A AR P970105696A AR 009651 A1 AR009651 A1 AR 009651A1
Authority
AR
Argentina
Prior art keywords
composition
solubilizing
indoline
stabilizing
pharmaceutical composition
Prior art date
Application number
ARP970105696A
Other languages
English (en)
Spanish (es)
Original Assignee
Kieger Stephane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kieger Stephane filed Critical Kieger Stephane
Publication of AR009651A1 publication Critical patent/AR009651A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ARP970105696A 1996-12-05 1997-12-04 Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas AR009651A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
AR009651A1 true AR009651A1 (es) 2000-04-26

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105696A AR009651A1 (es) 1996-12-05 1997-12-04 Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas

Country Status (25)

Country Link
EP (1) EP0941090A1 (fr)
JP (1) JP2000507618A (fr)
KR (1) KR20000069308A (fr)
CN (1) CN1239887A (fr)
AR (1) AR009651A1 (fr)
AU (1) AU716575B2 (fr)
BR (1) BR9712406A (fr)
CA (1) CA2273990A1 (fr)
CO (1) CO4910129A1 (fr)
DZ (1) DZ2362A1 (fr)
EE (1) EE9900206A (fr)
FR (1) FR2756736B1 (fr)
HU (1) HUP0001386A3 (fr)
ID (1) ID23373A (fr)
IL (1) IL129936A0 (fr)
IS (1) IS5062A (fr)
MY (1) MY132819A (fr)
NO (1) NO992724L (fr)
NZ (1) NZ335750A (fr)
RU (1) RU2174394C2 (fr)
SK (1) SK75599A3 (fr)
TR (1) TR199901702T2 (fr)
WO (1) WO1998024430A1 (fr)
YU (1) YU23099A (fr)
ZA (1) ZA9710919B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (fr) 1999-11-12 2006-06-14 Abbott Laboratories Dispersion solide comrpenant ritonavir, fenofibrate ou griseofulvin
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
HUP0001386A2 (hu) 2001-04-28
SK75599A3 (en) 2000-08-14
NO992724D0 (no) 1999-06-04
CO4910129A1 (es) 2000-04-24
CA2273990A1 (fr) 1998-06-11
NZ335750A (en) 2001-06-29
EP0941090A1 (fr) 1999-09-15
DZ2362A1 (fr) 2002-12-28
IS5062A (is) 1999-06-01
FR2756736B1 (fr) 1999-03-05
AU716575B2 (en) 2000-03-02
JP2000507618A (ja) 2000-06-20
YU23099A (en) 1999-11-22
AU5326298A (en) 1998-06-29
KR20000069308A (ko) 2000-11-25
RU2174394C2 (ru) 2001-10-10
ZA9710919B (en) 1999-06-04
TR199901702T2 (en) 1999-09-21
ID23373A (id) 2000-04-20
CN1239887A (zh) 1999-12-29
IL129936A0 (en) 2000-02-29
BR9712406A (pt) 1999-08-31
FR2756736A1 (fr) 1998-06-12
NO992724L (no) 1999-06-04
EE9900206A (et) 1999-12-15
WO1998024430A1 (fr) 1998-06-11
HUP0001386A3 (en) 2002-03-28
MY132819A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
AR009651A1 (es) Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas
FR2405711A1 (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
CO5560559A2 (es) Formulacion de suspension oral estabilizada
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
DE69940769D1 (de) Orale flüssige zusammensetzungen
BRPI0009249A (pt) formulação farmacêutica parenteral de equinocandina contendo tensoativos de formação de micela.
PT94485A (pt) Metodo para a preparacao de uma formulacao gel topica estavel, cosmeticamente aceitavel, contendo uma tetraciclina, util no tratamento do acne
ATE269708T1 (de) Formulierung enthaltend testosteonundecanoat und rizinusöl
ES2187467T3 (es) Composiciones liquidas de proteccion solar con buena deposicion y formacion de espuma.
PE20021017A1 (es) Composicion parenteral reconstituible
AR030064A1 (es) Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
DE69426570D1 (de) Mizelleförmige feinteilige pharmazeutische zusammensetzungen
ES2224917T1 (es) Composiciones farmaceuticas de agente fibrinolitico.
GB2391471B (en) Pharmaceutical compositions
JP4509552B2 (ja) 向上されたバイオアベイラビリティを有する経口医薬組成物
PE3096A1 (es) Formulacion conteniendo selenio
PE20070377A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
CA1249223A (fr) Formulations de medicaments solides et suspensions stables
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
RU99114019A (ru) Фармацевтические композиции, содержащие производные n-сульфонилиндолина
PE20010568A1 (es) Formulaciones orales de liberacion controlada
JPH0536412B2 (fr)
PE20030350A1 (es) Solvatos de clorhidrato de lercanipidina y novedosas formas cristalinas de clorhidrato de lercanidipina que se obtienen a partir de dichos solvatos
BRPI0416341A (pt) composição farmacêutica destinada à administração oral de um derivado de pirazol-3-carboxamida